Keir Starmer is set to appear at PMQs as he is under pressure to make a steel deal with Donald Trump after the US president ...

It was reported the chancellor left the central bank nine months earlier than she stated in her LinkedIn profile ...

Recap from the House of Commons as Sir Keir Starmer and Kemi Badenoch go head to head at Prime Minister's Questions.

Five years on, Brexit is still the gift that keeps on taking - THE INDEPENDENT VIEW: Editorial: In 2025, regret is the ...

This is an open access article distributed in accordance with the Creative Commons Attribution ... the efficacy of vaccines. Indeed, following the initial submission of this manuscript, the Omicron ...

The UK government has put lateral flow antigen tests (LFATs ... Review Boards/Review Cttes public policy This is an open access article distributed in accordance with the Creative Commons Attribution ...

The researchers also offered four key recommendations for how the UK can best level-up in cancer vaccine research. These recommendations are: Leverage COVID-19 vaccine success. Insights can be ...

“There’s no vaccine for ... in the House of Commons therefore sought to explain that £12m gap, stating that the pharma company was reducing its investment in UK-based research and development ...

AstraZeneca Plc abandoned plans to invest £450 million ($558 million) in a UK vaccine manufacturing plant, following protracted wrangling with the new Labour government over the level of state ...

“There’s no vaccine for incompetence ... told the House of Commons there was “a significant change in the [...] proposed investment [by AstraZeneca], resulting in a smaller level of research and ...

A central challenge for the UK in developing cancer vaccines lies in harnessing national infrastructure, particularly the country's healthcare system, to facilitate efficient trials.